Outcomes of patients with human immunodeficiency virus infection undergoing cardiovascular surgery in the United States

Keyphrases

• AIDS/HIV 100%
• United States 100%
• Patient Outcomes 100%
• Human Immunodeficiency Virus Infection 100%
• Cardiovascular Surgery 100%
• Human Immunodeficiency Virus Patients 80%
• Blood Transfusion 40%
• Highly Active Antiretroviral Therapy (HAART) 20%
• Perioperative Stroke 20%
• Length of Stay 20%
• Pneumonia 20%
• Postoperative Complications 20%
• Renal Failure 20%
• Patients Included 20%
• Virus Status 20%
• Medicaid 20%
• Metastatic Cancer 20%
• Hospital Mortality 20%
• Coagulopathy 20%
• Wound Infection 20%
• In-hospital Death 20%
• Propensity Matching 20%
• Renal Complications 20%
• Combined Surgery 20%
• Inpatient Mortality 20%

Medicine and Dentistry

• Human Immunodeficiency Virus 100%
• Human Immunodeficiency Virus Infection 100%
• Cardiovascular Surgery 100%
• Patient with Human Immunodeficiency Virus 100%
• Blood Transfusion 33%
• Renal Failure 16%
• Apoplexy 16%
• Health Care Cost 16%
• Lifespan 16%
• Metastatic Carcinoma 16%
• Postoperative Complication 16%
• Hospital Mortality 16%
• Surgical Technique 16%
• Coagulopathy 16%
• Highly Active Antiretroviral Therapy 16%
• Wound Infection 16%
• Medicaid 16%
• Pneumonia 16%

Nursing and Health Professions

• Human Immunodeficiency Virus 100%
• Human Immunodeficiency Virus Infection 100%
• Cardiovascular Surgery 100%
• Patient with Human Immunodeficiency Virus 100%
• Blood Transfusion 33%
• Highly Active Antiretroviral Therapy 16%
• Kidney Failure 16%
• Hospital Mortality 16%
• Length of Stay 16%
• Surgical Technique 16%
• Wound Infection 16%
• Cerebrovascular Accident 16%
• Postoperative Complication 16%
• Medicaid 16%
• Blood Clotting Disorder 16%
• Pneumonia 16%